← brief for 2026-08-29 · Slowing decline

In-Hospital Empagliflozin Therapy for Congestion Relief and Renal Function in Patients with Acute Decompensated Heart Failure: A Structured Review

Key takeaways

A review of using empagliflozin, an SGLT2 diabetes drug that also protects kidneys, in hospital for people with sudden worsening heart failure. It looks at whether the drug clears fluid buildup without harming kidney function. This is a structured summary of studies others ran, not a new trial, so it shows patterns rather than proof. It was posted to a repository and has not been peer reviewed.

Who did this work

E. D. Rivadeneira¹*, J. T. Alvarez², M. L. Jaraba³, A. C. Montiel⁴, A. M. Baquero5

Source

Paper · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-08-28
https://doi.org/10.5281/zenodo.22145345